In resistant hypertension, amiloride was noninferior to spironolactone for reducing home SBP at 12 wk

Authors

Niccolò Bonini (ORCID: https://orcid.org/0000-0002-2766-5286)
Giulio Francesco Romiti (ORCID: https://orcid.org/0000-0002-3788-8942)

Institutions

Azienda Ospedaliero-Universitaria di Modena (IT)
Sapienza University of Rome (IT)

Publication Details

Journal: Annals of Internal Medicine
Published: 2025-09-01
DOI: https://doi.org/10.7326/annals-25-03345-jc
Primary Topic: Hormonal Regulation and Hypertension
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

In resistant hypertension, amiloride was noninferior to spironolactone for reducing home SBP at 12 wk

Niccolò Bonini, Giulio Francesco Romiti

Sep 1, 2025

Annals of Internal Medicine

Hormonal Regulation and Hypertension

article

In resistant hypertension, amiloride was noninferior to spironolactone for reducing home SBP at 12 wk

Niccolò Bonini, Giulio Francesco Romiti

September 1, 2025article en

Abstract

No abstract available for this paper.

Annals of Internal MedicineVol. 178(9)

Azienda Ospedaliero-Universitaria di Modena (IT), Sapienza University of Rome (IT)

Openalex Percentile: Top 68%

Hormonal Regulation and Hypertension

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In resistant hypertension, amiloride was noninferior to spironolactone for reducing home SBP at 12 wk — Niccolò Bonini, Giulio Francesco Romiti · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS